IMO (based on DD) there is little doubt that it will work regardless of whether TNBC or other metastatic cancer due to CCR5 and leronlimab’s mechanism of action.
Great times ahead and yes 300 meter target is getting closer and hopefully we knock down that 25 meter target before hand-to-hand combat is required!
(0)
(0)
CytoDyn Inc (CYDY) Stock Research Links
Please do your own due diligence. All my posts and comments are not to be considered investment advice.